The effectiveness of interventions to treat severe acute malnutrition in young children
Citation: Picot J., Hartwell D., Harris P., et al. The effectiveness of interventions to treat severe acute malnutrition in young children: A systematic review. Health Technology Assessment, (2012). 16(19), 1-100
Further research is required on most aspects of the management of severe acute malnutrition (SAM) in children < 5 years, including intravenous resuscitation regimens for shock, management of subgroups (e.g. infants < 6 months old, infants and children with SAM who are human immunodeficiency virus sero-positive) and on the use of antibiotics.
SAM can occur following sudden food shortage and has been associated with loss of body fat and skeletal muscle wasting. To date, different forms of intervention and treatments for SAM still result in high levels of mortality and morbidity. This review aimed to assess the effectiveness of interventions treating SAM in children aged < 5. Seventy-four articles were included for review, assessed and checked for quality by two authors. Results showed hypo-osmolar oral rehydration solution (H-ORS) benefited children with acute diarrhea, compared with the standard World Health Organization-oral rehydration solution (WHO- ORS), no significant difference was observed between the results of using WHO- ORS and rehydration solution for malnutrition (ReSoMal). Rice-based ORS was more beneficial than glucose-based ORS. WHO-ORS plus zinc had favorable outcomes on treatment of diarrhea. When treating infection in children with persistent diarrhea, no significant effect on recovery was found for amoxicillin, nor ceftriaxone when compared to no antibiotic provision. Inpatient treatment for SAM was considered as effective as treatment in home, or other settings. Many trials evaluated the effects of zinc on treating SAM but no firm conclusion was reached. Limited evidence was obtained regarding supplementary potassium or nicotinic acid and nucleotides. No evidence was found relating to treatment of children with SAM who were human immunodeficiency virus sero-positive, nor for SAM in infants < 6 months old. No evidence was found in relation to long-term survival, readmission rates, clinical effectiveness of management strategies for treating children with comorbidities, nor for program sustainability. Key questions were prioritized for this review according to a Delphi study and did not cover all areas of SAM management.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence the prevention and treatment of malnutrition but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about prevention or treatment of malnutirition on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.